Literature DB >> 26770399

Vitamin D3 alters Toll-like receptor 4 signaling in monocytes of pregnant women at risk for preeclampsia.

Lei Qian1, Hongyou Wang1, Fenghui Wu1, Ming Li1, Wei Chen1, Lianzheng Lv2.   

Abstract

Vitamin D deficiency during pregnancy is thought to play a role in the development of preeclampsia; however, the underlying mechanism is not fully understood. In this study, a randomized double-blind placebo-controlled clinical trial was performed among 60 pregnant women at risk for pre-eclampsia according to abnormal uterine artery Doppler waveform. Subjects were randomly divided into 2 groups to receive a daily dose of 2000 IU vitamin D3 supplements (n=30) or receive placebo (n=30) between gestational weeks 20-32 for a total of 12 consecutive weeks. Because vitamin D3 supplementation can induce anti-inflammatory cytokine signaling, peripheral blood monocytes were investigated by flow cytometry for expression of toll-like receptor 4 (TLR4), an important mediator of innate immune response. The pro-inflammatory cytokines secretion of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1 from monocytes, which are typically upregulated in preeclampsia, was also assessed. The incidence of preeclampsia was significantly lower in patients treated with vitamin D3 compared to the placebo group. Both the mean fluorescence intensity and the positive percentage of monocytes TLR4 in the vitamin D group were significantly lower compared to the placebo group, as well as the concentrations of secreted TNF-α, IL-6, and IL-1, while the concentration of IL-10 was higher. In the placebo group, the positive frequency of monocytes TLR4 was negatively correlated with the concentration of serum 25-hydroxyvitamin D in preeclampsia patients. Based on these results, we conclude that vitamin D3 supplementation for patients at risk of preeclampsia leads to a decrease in the expression of peripheral blood monocytes TLR4 and a subsequent decrease in pro-inflammatory cytokine secretion. Therefore, inhibiting the expression of monocytes TLR4 through vitamin D3 supplement may be a new approach to preeclampsia prevention.

Entities:  

Keywords:  Preeclampsia; Toll-like receptor 4; monocytes; vitamin D3

Year:  2015        PMID: 26770399      PMCID: PMC4694299     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  29 in total

1.  Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia.

Authors:  Attila Molvarec; András Szarka; Szilvia Walentin; Gabriella Beko; István Karádi; Zoltán Prohászka; János Rigó
Journal:  Clin Chim Acta       Date:  2011-07-06       Impact factor: 3.786

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 3.  Vitamin D effects on lung immunity and respiratory diseases.

Authors:  Sif Hansdottir; Martha M Monick
Journal:  Vitam Horm       Date:  2011       Impact factor: 3.421

Review 4.  Vitamin D supplementation during pregnancy: safety considerations in the design and interpretation of clinical trials.

Authors:  D E Roth
Journal:  J Perinatol       Date:  2011-01-20       Impact factor: 2.521

Review 5.  Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities: an emerging hypothesis for neuropathy and gastrointestinal toxicity.

Authors:  Hannah R Wardill; Ysabella Z A Van Sebille; Kimberley A Mander; Rachel J Gibson; Richard M Logan; Joanne M Bowen; Stephen T Sonis
Journal:  Cancer Treat Rev       Date:  2014-12-05       Impact factor: 12.111

6.  A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia.

Authors:  Arthur M Baker; Sina Haeri; Carlos A Camargo; Janice A Espinola; Alison M Stuebe
Journal:  J Clin Endocrinol Metab       Date:  2010-08-18       Impact factor: 5.958

7.  Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.

Authors:  L Poston; A L Briley; P T Seed; F J Kelly; A H Shennan
Journal:  Lancet       Date:  2006-04-08       Impact factor: 79.321

8.  Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women.

Authors:  Margaretha Haugen; Anne Lise Brantsaeter; Lill Trogstad; Jan Alexander; Christine Roth; Per Magnus; Helle Margrete Meltzer
Journal:  Epidemiology       Date:  2009-09       Impact factor: 4.822

9.  Calcitriol inhibits TNF-alpha-induced inflammatory cytokines in human trophoblasts.

Authors:  Lorenza Díaz; Nancy Noyola-Martínez; David Barrera; Guillermo Hernández; Euclides Avila; Ali Halhali; Fernando Larrea
Journal:  J Reprod Immunol       Date:  2009-06-06       Impact factor: 4.054

10.  First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.

Authors:  Zheng Bian; Chenzi Shixia; Tao Duan
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

View more
  8 in total

1.  Curcumin inhibits placental inflammation to ameliorate LPS-induced adverse pregnancy outcomes in mice via upregulation of phosphorylated Akt.

Authors:  Jianjun Zhou; Huishuang Miao; Xiujun Li; Yali Hu; Haixiang Sun; Yayi Hou
Journal:  Inflamm Res       Date:  2016-11-05       Impact factor: 4.575

Review 2.  Targeting toll-like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension?

Authors:  Kenia Pedrosa Nunes; Amanda Almeida de Oliveira; Francesca Elisabeth Mowry; Vinicia Campana Biancardi
Journal:  Br J Pharmacol       Date:  2018-08-09       Impact factor: 8.739

Review 3.  Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review.

Authors:  Jaume Alijotas-Reig; Enrique Esteve-Valverde; Raquel Ferrer-Oliveras; Elisa Llurba; Josep Maria Gris
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

4.  Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia.

Authors:  Guang-Sheng Lei; Chen Zhang; Bi-Hua Cheng; Chao-Hung Lee
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

5.  Vitamin D supplementation for women during pregnancy.

Authors:  Cristina Palacios; Lia K Kostiuk; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2019-07-26

6.  Peritraumatic Vitamin D Levels Predict Chronic Pain Severity and Contribute to Racial Differences in Pain Outcomes Following Major Thermal Burn Injury.

Authors:  Matthew C Mauck; Chloe E Barton; Andrew Tungate; Jeffrey W Shupp; Rachel Karlnoski; David J Smith; Felicia N Williams; Samuel W Jones; Kyle V McGrath; Bruce A Cairns; Samuel A McLean
Journal:  J Burn Care Res       Date:  2021-11-24       Impact factor: 1.845

7.  Prenatal high-dose vitamin D3 supplementation has balanced effects on cord blood Th1 and Th2 responses.

Authors:  Evana Akhtar; Akhirunnesa Mily; Ahsanul Haq; Abdullah Al-Mahmud; Shams El-Arifeen; Abdullah Hel Baqui; Daniel E Roth; Rubhana Raqib
Journal:  Nutr J       Date:  2016-08-09       Impact factor: 3.271

Review 8.  The Role of Toll-Like Receptors and Vitamin D in Cardiovascular Diseases-A Review.

Authors:  Daria M Adamczak
Journal:  Int J Mol Sci       Date:  2017-10-27       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.